Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
The rupee has hit fresh record lows near 96.5 to 97 per dollar as crude stays elevated, US yields rise, and risk-off sentiment pressures emerging markets.
RBI injected ₹81,590 crore via a three-day VRR at 5.26% as surplus liquidity tightened sharply, pushing overnight call money rates higher and keeping demand below ₹100,000 crore.
Emirates NBD plans a ₹26,850 crore primary infusion in RBL Bank, plus an open offer, after key approvals from RBI, CCI and the finance ministry.
India’s Steel Ministry has urged the Finance Ministry to withdraw anti-dumping duty on low-ash met coke imports, citing shortages, rising domestic prices, and higher costs for steel producers.
Swelect Energy reported sharp year-on-year growth in March 2025 standalone and consolidated net sales, alongside quarterly and annual profit and margin data across FY25 and early FY26.
Sun Pharma reported a 26.2% YoY rise in Q4 FY26 net profit to ₹2,714 crore, announced a ₹5 final dividend, and posted FY26 sales growth of 11.9%.
Vaibhav Global reported a 167% year-on-year jump in Q4 FY26 profit to ₹91.14 crore on 10% revenue growth, alongside improving margins and a ₹1.50 final dividend.
Repco Home Finance reported Q4 FY26 net profit of ₹129 crore with higher total income, while loan sanctions and disbursements rose sharply for the quarter and full year.
M.K. Exim (India) informed BSE about multiple board meetings in 2025-26 covering quarterly results approvals, audited accounts, governance reviews, key appointments, and trading window closure timelines.
RBI and the Finance Ministry have cleared Emirates NBD’s $3 billion plan to acquire up to 74% of RBL Bank via a ₹280 preferential issue and open offer.
Swiggy’s bid to become an Indian Owned and Controlled Company hit a roadblock after shareholders rejected an AoA amendment, citing governance and founder-control concerns.
RBI has allowed INR lending to Bhutan, Nepal and Sri Lanka, plans new FBIL reference rates, and expands SRVA investment avenues to support rupee-based trade settlement.
Dr Agarwal's Health Care reported Q4 FY26 net profit of INR 50 crore on revenue from operations of about INR 564 crore, while FY26 PAT rose to INR 168 crore.
Fortis Healthcare grew Q4 FY25 revenue 12.4% to INR 2,007 crore, but net profit fell 7.4% to INR 188 crore due to higher expenses and impairments.
NSE said Exide Industries and Nuvama Wealth will stop getting new F&O expiries after the current series, with trading ending in these contracts from July 29, 2026.
SAMHI Hotels reported strong Q3 FY26 numbers with 16.2% YoY income growth, 13.2% EBITDA growth after GST changes, and PAT up 111.3% to INR 481 million.